Delta16 transgenic mice express an activated isoform of human HER-2 under the transcriptional control of a mouse mammary tumor virus long terminal repeat, leading to the development of multiple mammary carcinomas in all female mice during the first year of life. Here, ERBB2 is linked to breast carcinoma.